Nano-X Imaging (NNOX) EBITDA (2019 - 2026)

Nano-X Imaging (NNOX) has reported EBITDA for 8 consecutive years, with -$14.6 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, EBITDA fell 3.32% year-over-year to -$14.6 million; the trailing twelve-month figure through Mar 2026 stood at -$78.4 million (down 36.51% YoY), and the FY2025 full-year result was -$78.2 million, down 37.87% from the prior year.
• EBITDA climbed to -$14.6 million in Q1 2026 per NNOX's latest filing, from -$35.4 million in the prior quarter.
• Across five years, EBITDA topped out at -$10.7 million in Q4 2023 and bottomed at -$53.8 million in Q4 2022.
• Historically, EBITDA has averaged -$19.4 million across 5 years, with a median of -$14.6 million in 2026.
• The sharpest annual moves came in 2022 and 2023: EBITDA slumped 145.29% in 2022, then soared 80.12% in 2023.
• Over 5 years, EBITDA stood at -$53.8 million in 2022, then jumped by 80.12% to -$10.7 million in 2023, then plunged by 40.12% to -$15.0 million in 2024, then slumped by 136.51% to -$35.4 million in 2025, then surged by 58.9% to -$14.6 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered -$14.6 million, -$35.4 million, and -$14.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.